TY - JOUR
T1 - Exercise-based cardiac rehabilitation in patients with reduced left ventricular ejection fraction: The Cardiac Rehabilitation Outcome Study in Heart Failure (CROS-HF)
T2 - A systematic review and meta-analysis
AU - German Society of Cardiovascular Prevention and Rehabilitation (DGPR)
AU - Bjarnason-Wehrens, Birna
AU - Nebel, R
AU - Jensen, K
AU - Hackbusch, M
AU - Grilli, M
AU - Gielen, S
AU - Schwaab, B
AU - Rauch, B
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Background: In
heart failure with reduced left ventricular ejection fraction (HFrEF)
patients the effects of exercise-based cardiac rehabilitation on top of
state-of-the-art pharmacological and device therapy on mortality,
hospitalization, exercise capacity and quality-of-life are not well
established.Design: The design of this study involved a structured review and meta-analysis.Methods: Evaluation
of randomised controlled trials of exercise-based cardiac
rehabilitation in HFrEF-patients with left ventricular ejection fraction
≤40% of any aetiology with a follow-up of ≥6 months published in 1999
or later.Results: Out
of 12,229 abstracts, 25 randomised controlled trials including 4481
HFrEF-patients were included in the final evaluation. Heterogeneity in
study population, study design and exercise-based cardiac
rehabilitation-intervention was evident. No significant difference in
the effect of exercise-based cardiac rehabilitation on mortality
compared to control-group was found (hazard ratio 0.75, 95% confidence
interval 0.39–1.41, four studies; 12-months follow-up: relative risk
1.29, 95% confidence interval 0.66–2.49, eight studies; six-months
follow-up: relative risk 0.91, 95% confidence interval 0.26–3.16, seven
studies). In addition there was no significant difference between the
groups with respect to ‘hospitalization-for-any-reason’ (12-months
follow-up: relative risk 0.79, 95% confidence interval 0.41–1.53, four
studies), or ‘hospitalization-due-to-heart-failure’ (12-months
follow-up: relative risk 0.59, 95% confidence interval 0.12–2.91, four
studies; six-months follow-up: relative risk 0.84, 95% confidence
interval 0.07–9.71, three studies). All studies show improvement of
exercise capacity. Participation in exercise-based cardiac
rehabilitation significantly improved quality-of-life as evaluated with
the Kansas City Cardiomyopathy Questionnaire: (six-months follow-up:
mean difference 1.94, 95% confidence interval 0.35–3.56, two studies),
but no significant results emerged for quality-of-life measured by the
Minnesota Living with Heart Failure Questionnaire (nine-months or more
follow-up: mean difference –4.19, 95% confidence interval –10.51–2.12,
seven studies; six-months follow-up: mean difference –5.97, 95%
confidence interval –16.17–4.23, four studies).Conclusion: No
association between exercise-based cardiac rehabilitation and mortality
or hospitalisation could be observed in HFrEF patients but
exercise-based cardiac rehabilitation is likely to improve exercise
capacity and quality of life.
AB - Background: In
heart failure with reduced left ventricular ejection fraction (HFrEF)
patients the effects of exercise-based cardiac rehabilitation on top of
state-of-the-art pharmacological and device therapy on mortality,
hospitalization, exercise capacity and quality-of-life are not well
established.Design: The design of this study involved a structured review and meta-analysis.Methods: Evaluation
of randomised controlled trials of exercise-based cardiac
rehabilitation in HFrEF-patients with left ventricular ejection fraction
≤40% of any aetiology with a follow-up of ≥6 months published in 1999
or later.Results: Out
of 12,229 abstracts, 25 randomised controlled trials including 4481
HFrEF-patients were included in the final evaluation. Heterogeneity in
study population, study design and exercise-based cardiac
rehabilitation-intervention was evident. No significant difference in
the effect of exercise-based cardiac rehabilitation on mortality
compared to control-group was found (hazard ratio 0.75, 95% confidence
interval 0.39–1.41, four studies; 12-months follow-up: relative risk
1.29, 95% confidence interval 0.66–2.49, eight studies; six-months
follow-up: relative risk 0.91, 95% confidence interval 0.26–3.16, seven
studies). In addition there was no significant difference between the
groups with respect to ‘hospitalization-for-any-reason’ (12-months
follow-up: relative risk 0.79, 95% confidence interval 0.41–1.53, four
studies), or ‘hospitalization-due-to-heart-failure’ (12-months
follow-up: relative risk 0.59, 95% confidence interval 0.12–2.91, four
studies; six-months follow-up: relative risk 0.84, 95% confidence
interval 0.07–9.71, three studies). All studies show improvement of
exercise capacity. Participation in exercise-based cardiac
rehabilitation significantly improved quality-of-life as evaluated with
the Kansas City Cardiomyopathy Questionnaire: (six-months follow-up:
mean difference 1.94, 95% confidence interval 0.35–3.56, two studies),
but no significant results emerged for quality-of-life measured by the
Minnesota Living with Heart Failure Questionnaire (nine-months or more
follow-up: mean difference –4.19, 95% confidence interval –10.51–2.12,
seven studies; six-months follow-up: mean difference –5.97, 95%
confidence interval –16.17–4.23, four studies).Conclusion: No
association between exercise-based cardiac rehabilitation and mortality
or hospitalisation could be observed in HFrEF patients but
exercise-based cardiac rehabilitation is likely to improve exercise
capacity and quality of life.
KW - left ventricular ejection fraction
KW - cardiac rehabilitation
KW - heart failure
KW - exercise
KW - heterogeneity
KW - exercise tolerance
KW - follow-up
KW - mortality
KW - quality of life
KW - heart failure with reduced ejection fraction
UR - https://www.mendeley.com/catalogue/38fe9f1d-ddcb-3e5f-abc3-35f4f125861b/
U2 - 10.1177/2047487319854140
DO - 10.1177/2047487319854140
M3 - Journal articles
C2 - 31177833
SN - 2047-4881
SN - 2047-4873
VL - 27
SP - 929
EP - 952
JO - European journal of preventive cardiology
JF - European journal of preventive cardiology
IS - 9
ER -